Locally Recurrent Breast Cancer
📧 Sign up to get email alerts when something new happens for Locally Recurrent Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer [Phase 1]
This clinical trial update reports on Z-Endoxifen Hydrochloride being studied for estrogen receptor-positive breast cancer that is metastati…
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer [Phase 3]
A Phase 3 pivotal study in HER2-negative locally recurrent or metastatic breast cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Revisiting Omental Transposition in Locally Advance and Locally Recurrent Breast Cancer
Clinical trial evaluating omental transposition for locally advanced and locally recurrent breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer [Phase 2]
Phase 2 trial of lapatinib with radiation therapy for locally advanced or locally recurrent breast cancer; the study was terminated with res…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating single-agent eribulin mesylate as first-line therapy for locally recurrent or metastatic HER2-negative breast can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer [NA]
A completed bioequivalence study comparing IG-001 to nab-paclitaxel in metastatic or locally recurrent breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating imetelstat in combination with paclitaxel, with or without bevacizumab, in locally recurrent or metastatic breast…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. [Phase 3]
A Phase 3 clinical trial evaluating Avastin (bevacizumab) plus taxane-based therapy for locally recurrent or metastatic breast cancer has co…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating adjuvant chemotherapy after surgical resection for relapsed or locally recurrent breast cancer; results we…